欢迎您！东篱公司
退出
-
申报数据库
-
立项数据库
-
成果数据库
-
项目获奖数据库
中文摘要：
目的：观察益心泰治疗急性心肌梗死的临床疗效及对醛固酮（Aldsterone，ALD）水平的影响。方法：将符合纳入标准的60例急性心肌梗死患者随机分为治疗组和对照组各30例，两组均给予常规心肌梗死治疗，治疗组在常规治疗基础上加用益心泰治疗，每次10g，口服，每天3次，6周为1个疗程，观察1个疗程后比较两组疗效、心电图的改善、心脏彩超的变化、酶学检查以及ALD水平的变化情况。结果：两组治疗6周后的临床症状和客观指征均明显改善，治疗组优于对照组（P〈0．05）。结论：益心泰可以降低急性心肌梗死惠者ALD水平，阻止心室重构。
英文摘要：
Objective： To observe the therapeutic efficacy of Yixintai in the treatment of acute myocardial in-farction and the effect of Yixintai on aldosterone （ALD） level. Methods： Sixty patients with acute myocardial in-farction were randomly divided into treatment group （ n=30 ） and control group （ n = 30）. Both group received conventional therapy for myocardial infarction. Additionally, each patient in the treatment group was orally given Yixintai 3 times （10 g each time） every day for 6 weeks （one period of treatment）. The two groups were compared with respect to therapeutic efficacy, electrocardiogram improvement, ultrasonic cardiogram change, enzyme exami-nation results, and ALD level. Results ： After 6 weeks of treatment, both groups showed significant improvement in clinical symptoms and the above indices, and the treatment group was significantly better than the control group in these tients regards （ P 〈 O. 05 ）. Conclusion ： Yixintai can decrease ALD level and inhibit ventricular remodeling in pa-with acute myocardial infarction.
同期刊论文项目
同项目期刊论文
期刊信息
位置：